Introduction
Several studies have attempted to identify prognostic factors for patients with heart failure and left-ventricular (LV) systolic dysfunction [1] [2] [3] [4] [5] [6] . It is now recognized that Doppler echocardiography, including both systolic and diastolic parameters, provides information regarding the prognosis in this population [1] [2] [3] [4] [5] [6] . However, patients with atrial fibrillation (AF) were generally excluded from these studies, limiting the applicability of these echocardiographic parameters to patients in sinus rhythm (SR). Nevertheless, 20 to 40% of patients with chronic heart failure have AF [7, 8] , indicating that this is a common finding in these patients. Among the various diastolic variables, an early-to-late filling velocity ratio greater than 2 (E/A ratio) and a short deceleration time of early transmitral filling are clearly recognized as powerful predictors of poor prognosis in heart-failure patients with LV systolic dysfunction and SR [1] [2] [3] [4] [5] [6] .
Given the high incidence of AF among patients with LV systolic dysfunction, it would be useful to determine whether pulsed-wave Doppler recording of mitral inflow could also provide prognostic information, even in the presence of AF. Indeed, very little information is available on diastolic filling and outcome of heart-failure patients with LV systolic dysfunction and AF [7, 8] . Because of the monophasic E wave resulting from the AF state, the deceleration time of mitral inflow E velocity (E-wave DT) could be used to analyse the prognostic value in heart-failure patients with LV systolic dysfunction and AF. To test this hypothesis, we decided to assess whether a short deceleration time of the E wave recorded in heart-failure patients with LV systolic dysfunction could predict a poor prognosis even in the presence of AF. The objective of this prospective study was also to compare the prognostic value of this Doppler index in patients in AF with those of patients in SR.
Methods

Patients
We prospectively included, between February 1996 and November 1998, consecutive patients hospitalised with clinical congestive heart failure (CHF) and LV systolic dysfunction. The inclusion criteria were as follows:
• LV ejection fraction less than 40% on echocardiographic examination; • absence of valvular heart disease;
• absence of a permanent pacemaker;
• clinical stability for at least three weeks;
• acceptable acoustic window.
Patients with chronic AF (i.e., greater than one month) were documented by previous electrocardiogram. All patients gave informed consent to participate in the study.
Echocardiographic examination
All echocardiographic measurements were performed after three weeks of clinical stability following an episode of congestive heart failure and under optimal therapy. All studies were analysed without knowledge of the clinical data. Entire echocardiography and Doppler examination were completed for each patient (Sonos 2000 or 5500, Philips Ultrasound system, probe 2.5 MHz), including measurements of LV diastolic and systolic diameters and LV diastolic and systolic volumes using the biplane Simpson's method. LV ejection fraction and shortening fraction were calculated. Tricuspid regurgitation was recorded and pulmonary systolic-artery pressure calculated. Mitral-flow velocity was assessed by pulsed-wave Doppler echocardiography in the apical four-chamber view with the sample volume placed between the tips of the mitral leaflets, where maximal flow velocity was recorded [9] . The peak velocities of the early filling (E) wave and the atrial contraction (A) wave were measured and their ratio (E/A) was calculated in patients with SR. The E-wave DT was calculated as the time between peak E wave and the upper deceleration slope by extrapolation to the zero baseline. For all measurements of Doppler variables, five to 10 consecutive beats were analysed and averaged. Mitral-Doppler tracings of sufficient quality were obtained in all patients.
Follow-up data
For evaluation of clinical outcome, the follow-up period was defined as beginning on the day after echocardiographic examination. The major endpoint was total mortality. Follow-up information was obtained from the review of visit and hospital records, when available, or by direct mail questionnaire or by telephone contact with the patients, their relatives or physicians regarding death, cardiac (sudden death, progressive pump failure, cardiac transplantation) and noncardiac.
Statistical analysis
Results are presented as mean plus or minus standard deviation (S.D.). A two-sample t test was performed to compare continuous variables. The chi-square test was used to compare categorical variables (with Yates' correction or Fisher's exact test, as appropriate, in smaller sample size). The Kaplan-Meier method was used for cumulative survival analysis with the log-rank test for assessing statistical differences between curves. E-wave DT, considered as a continuous value, was also treated as a dichotomous variable with an arbitrarily chosen cut-off of 150 ms corresponding to the value considered in clinical practice that could best discriminate between the two groups of patients [1, 10, 11] . The clinical, echocardiographic and Doppler variables were compared regarding prognostic significance for predicting mortality using the Cox proportional-hazards model. Baseline variables that had an association with mortality at a p value less than 0.05 by univariate analyses were included in the multivariable Cox model, selected according to a backward stepwise selection process and entered into or removed from the regression equation on the basis of a computed significance probability value. A p value less than 0.05 was considered statistically significant. Global chi-squares together with odds-ratios (ORs) are given for the multivariable Cox models.
Reproducibility
The reproducibility of E-wave DT measurement was assessed in 30 randomly selected patients. To test intra-and interobserver variability, the same examiner and another independent observer measured mitral flow on videotape that contained selected beats. Intra-and interobserver variations were assessed as the mean ± 1 S.D. difference between the two sets of observations. Mean percent error was calculated as the absolute difference divided by the average of the two observations. In addition, Kappa statistics were used to determine intra-and interobserver concordances for predicting E-wave DT less or equal to 150 ms.
Results
Patient characteristics
The study population comprised 140 patients with a mean age of 65 ± 11 years (115 men, 25 women). One hundred (71%) patients were in SR (21 women, 79 men), with a mean age of 65 ± 11 years and 40 (29%) were in AF (four women, 36 men), with a mean age of 68 ± 12 years (p = 0.08). Mean LV ejection fraction was of 33 ± 7%. The baseline clinical, mode-M and Doppler echocardiographic, aetiological and therapeutic characteristics of study patients are summarized in Table 1 . Underlying diagnoses and use of pharmacological medications, except for digoxin and amiodarone, were similar in patients with AF and in patients with SR. Echocardiographic LV diameters in the AF group were slightly lower than those in the SR group. Conversely, left and right atrial areas were higher in the AF group. Mean E-wave DT was 169 ± 64 ms in the global population. In the AF group, E-wave DT was lower (150 ± 48 ms versus 176 ± 68 ms; p = 0.05) and peak E velocity significantly higher than in the SR group (102 ± 30 ms versus 77 ± 24 ms; p < 0.0001).
Baseline clinical and Doppler echocardiographic variables according to E-wave DT
Among the 76 patients with an E-wave DT less or equal to 150 ms, 25 (33%) were in AF and 51 (67%) in SR. The univariate analysis of clinical and Doppler echocardiographic variables stratified according to rhythm and related to Ewave DT are shown in Tables 2 and 3 . Multivariable logistic regression analysis revealed that systolic pulmonary arterial pressure and E-wave peak velocity were the only independent markers of E-wave DT less or equal to 150 ms.
Overall survival rates
The mean follow-up duration of the entire patient cohort was 25 ± 11 months (range: 1 to 48). No patient was lost to follow-up. Patients in the SR group were followed for a mean of 24 ± 10 months and those in the AF group for The estimated one-and two-years survival rates for the entire patient cohort were 91 and 77%, respectively. Survival rates did not differ significantly between the AF and SR groups (p = 0.89), with the respective one-and two-years survival rates of 87 and 74% in the AF group, compared with 85 and 75% in the SR group. Patients with an E-wave DT less or equal to 150 ms from the entire patient cohort had a poor prognosis compared with those with an E-wave DT greater than 150 ms (p < 0.0001). The respective oneand two-years survival rates were 77 and 60% for patients with E-wave DT less or equal to 150 ms versus 95 and 92% for patients with a E-wave DT greater than 150 ms. When patients were stratified according to rhythm, both patient groups (in SR and in AF) with a E-wave DT less or equal to 150 ms had a poor outcome compared with the two other patient groups with a E-wave DT greater than 150 ms. The cumulative mortality rates for both patient groups in AF and SR with E-wave DT less or equal to and greater than 150 ms determined by the Kaplan-Meier method are depicted in the Fig. 1 .
Predictors of survival by univariate analysis
The influence of baseline variables on survival in the entire cohort and in the AF and SR groups is shown in Table 4 . Similarly to other groups, survival in AF group was significantly lower in patients with shortened E-wave DT. In addition, decreased systolic-blood pressure, increased LV end-diastolic diameter and volume, increased LV endsystolic diameter and volume and decreased shortening fraction and LV ejection fraction were found to have a significant influence. 
Predictors of survival by multivariable analysis
Variables significant by multivariable analysis using Cox regression in a backward stepwise procedure for survival free of deaths are shown in Table 5 . In the multivariable analysis performed in all patients with LV systolic dysfunction, the independent determinants of survival were a shortened E-wave DT (p < 0.0001), a decreased LV ejection fraction (p = 0.002), a decrease in systolic-blood pressure (p = 0.01) and a functional class III or IV (p = 0.01). In addition, a shortened E-wave DT was also identified as a strong negative predictor of survival in the AF group (p = 0.02) as in the SR group (p = 0.002).
Reproducibility
Intra-and interobserver variations were 2 ± 11 and 5 ± 12 ms, respectively, with mean percent errors of 6% for the same observer and of 9% between the two observers. The intra-and interobserver concordances for predicting E-wave DT less or equal to 150 ms were 95% (kappa: 0.89) and 94% (kappa: 0.87), respectively. In 10 randomly patients from AF group, intra-and interobserver concordances for predicting 
Discussion
The present prospective study demonstrates that the E-wave DT, assessed by Doppler, is a reproducible, useful and reliable noninvasive tool for predicting the prognosis of patients with heart failure due to LV systolic dysfunction, even in the presence of AF. Specifically, we showed that a shortened E-wave DT (≤ 150 ms) as an index of LV diastolic restrictive filling could predict a similar poor outcome in patients with AF as with SR.
Relation of E-wave DT to filling pressure
Several haemodynamic studies have demonstrated the importance of assessing diastolic function and LV filling in patients with LV systolic dysfunction [12] [13] [14] [15] . As filling pressure increases, the nondistensible ventricle may induce a more rapid increase in diastolic pressure with a faster equilibration of left atrial and LV pressures, resulting in premature cessation of mitral flow and a short deceleration time of early filling [16] . These haemodynamic studies have clearly demonstrated a close negative correlation between deceleration time of early filling and pulmonary-artery wedge pressure in patients with LV systolic dysfunction and SR [14, 15] . In two previous studies conducted in patients in chronic AF with ischaemic or idiopathic-dilated dilated cardiomyopathy [16, 17] , E-wave DT was significantly and inversely related to mean pulmonary wedge pressure. Moreover, Temporelli et al. found that E-wave DT was identified as the sole independent predictor of pulmonary-wedge pressure and that a shortened DT less or equal to 120 ms reliably predicted a marked elevated pulmonary-wedge pressure (≥ 20 mmHg) with sensitivity and specificity of 100 and 96%, respectively [16] . Other studies [18, 19] found a weak relation in general between deceleration time and pulmonary-wedge pressure in the presence of AF. However, patients who were included in these later studies had both depressed or preserved LV systolic function with a wide variety of heart diseases. The fact that E-wave DT does not related to LV filling pressures in patients in SR with diastolic dysfunction secondary to hypertrophy or ischaemic heart disease and preserved LV systolic function may account for this discrepancy [13, 14, 20] . Furthermore, Nagueh et al. showed that the relation between E-wave DT and pulmonary-wedge pressure depended on the level of LV systolic function in patients with AF [19] . In the group of patients with depressed ejection fraction (< 45%), a good relation was observed between deceleration time and pulmonary-wedge pressure (R = − 0.78), whereas in the subgroup with preserved systolic function, no relation was found. This is not surprising since one would expect that even in AF early diastolic LV filling velocities are governed by the same interactions between LV and atrial pressures operating with SR [17] .
Prognostic implication of shortened Doppler-derived E-wave DT
Others and we had shown that Doppler-derived mitral flow variables are important indicators of mortality and worsening heart failure in various cardiac diseases [1] [2] [3] [4] [5] [6] 10] . In the majority of previous studies carried with either ischaemic or idiopathic dilated cardiomyopathy, restrictive mitral flow was independently associated with poor prognosis [1] [2] [3] [4] [5] [6] . However, these studies were performed exclusively in patients with SR, so their results could not be applied to patients with LV systolic dysfunction in the presence of AF. The present study, to our knowledge, is the first to demonstrate that Doppler-derived LV filling, specifically the short mitral deceleration time, is a powerful independent predictor of fatal outcome in heart-failure patients due to LV systolic dysfunction even in presence of AF. Atrial fibrillation is common in patients with advanced chronic-heart failure, but data regarding its clinical and prognostic significance are inconclusive [8, [21] [22] [23] [24] [25] . In our study, the presence of AF at baseline was not indepen-dently associated with adverse outcome in this population. Although limited by the relatively small patient group, our results are consistent with large series of patients with advanced chronic-heart failure and AF showing no difference in prognosis between AF and SR [23, 24] . These findings suggest that factors associated with chronic-heart failure or caused by AF may play a prognostic role in heart-failure patients with LV systolic dysfunction in AF. In the present study, a short E-wave DT was not only identified as independent predictor of a poor prognosis in heart-failure patients with LV systolic dysfunction and SR, but was also independently associated with an adverse prognosis in the presence of AF. To date, the prognostic implication of diastolic abnormalities in AF has been poorly investigated. Only one study examined the prognostic value of restrictive filling pattern in patients with AF. In this retrospective series, with a median follow-up of 2.2 years, Hurrell et al. showed that a shortened mitral DT less or equal to 130 ms predicted a similar poor prognosis in patients with AF as with SR [26] . However, patients of this study were selected for a very short E-wave DT and had a wide range of cardiac diseases with both normal and depressed ejection fractions. In the present study, we enrolled prospectively patients only on the basis of LV systolic function, irrespective of rhythm itself with a wide range of E-wave DT. Our findings indicate that a shortened mitral deceleration time appears to provide a poor prognosis in LV systolic dysfunction independently of rhythm itself, with a similar risk for patients with AF as with SR. Thus, it is reasonable to speculate that an increase in chamber stiffness due to extensive scarring and structural changes of myocardial tissue, accompanied by an increase in LV filling pressures and left-atrial pressures (as mentioned above in haemodynamic studies) is the most likely underlying mechanism of restrictive filling in patients with AF as with SR. However, it is well recognized that AF itself may lead to pathological and haemodynamic changes. These changes are caused by the loss of atrial contraction, irregular ventricular filling and inappropriately high heart rates, particularly during exercise. As a result, LV ejection, exercise capacity and peripheral flow decrease, leading to an increase in signs and symptoms as a worse NYHA functional class or a decrease in blood pressure. Therefore, it was not surprising that we identified a low ejection fraction and a decrease in blood pressure as being independently associated with adverse outcome in the group of patients with LV systolic dysfunction and AF.
Study limitations
This study has several potential limitations. Multiple factors can influence LV diastolic filling variables [27] [28] [29] , including the aging process, loading conditions, valvular regurgitation, heart rate and beat-to-beat variability. Our study was performed in a selected population of heart-failure patients with LV ejection fraction less than 40% without associated valvular regurgitation, in whom adequate ventricular-rate control had been obtained. Thus, the results of the current study cannot be generalized to other patients, in particular to those with preserved LV systolic function in SR or AF.
Age may have been unlikely to have a significant impact on our results, even if patients in the AF group were slightly older. Indeed, age was not independently related to either E-wave DT or adverse prognosis. No significant difference in heart rate was found between our two groups of patients with SR and AF or between those with E-wave DT less or equal to and greater than 150 ms. The loading conditions of patients were not characterized in this study, but might have been influenced by patients' medications. However, the distribution of diuretic agents, angiotensin-converting enzyme inhibitors and nitrates was similar between the two groups of patients with SR and AF as between the two groups with E-wave DT less or equal to and greater than 150 ms.
Pulmonary venous flow Doppler was not examined in our study, which may have enhanced the ability to identify restrictive LV filling in patients with AF [17, 18] . However, use alone of pulmonary venous-flow parameters may not be as predictive in AF as in SR [17, 18, 30] . The peak acceleration of mitral velocity and isovolumic relaxation time may also provide additional useful information [17, 19] . We did not also consider other diastolic function indices as derived from tissue Doppler of mitral annulus or colour M-mode Doppler of mitral inflow because these relatively recent methods were not routinely performed at the outset of our study. However, the aim of this study was to investigate whether analysis of only mitral flow velocity profile, which is easy to obtain in all patients and is extensively used in the noninvasive assessment of LV filling abnormalities, would provide accurate prognostic information in patients with LV systolic dysfunction with SR as with AF.
Furthermore, AF is associated with changing diastolic time intervals that could make it difficult to analyse the haemodynamics of LV filling. Nagueh et al. demonstrated less variability of E velocities and deceleration time between different cardiac cycles in patients with increased LV filling pressures (> 15 mmHg) than in those with lower pressures [19] . To minimize variation in cardiac cycles, our echocardiographic studies were performed after three weeks of clinical stability under optimal therapy, such that the length of diastole should remain the most stable when recording deceleration time. It should also be noted that the use of a single Doppler echocardiographic study to assess prognosis has limitations because LV diastolic filling velocity profile may change over time with long-term medical treatment. Therefore, further studies involving larger numbers of patients with serial Doppler echocardiographic follow-up are required to better understand the mechanisms involved in diastolic changes affecting the prognosis of patients with LV poor systolic function and AF.
Conclusions
Despite the limitations discussed above, the present data show that mitral E-wave DT recorded by Doppler echocardiography can provide valuable prognostic information in heart-failure patients with ventricular systolic dysfunction, even in the presence of AF. Defined as an index of restrictive filling, a shortened mitral DT appears to predict a similar poor prognosis in LV systolic dysfunction with AF as with SR. Because the determination of mitral E-wave DT is feasible, reproducible and accurate in the presence of AF, it should be included definitively in the noninvasive prognostic evalu-ation of all patients with LV systolic dysfunction, irrespective of the underlying rhythm.
